Evidence map›Paper›PMID 33524392›Full record

ArticleThe Journal of biological chemistry

The molecular basis of OH-PCB estrogen receptor activation.

Ting Wang, Ian Cook, Thomas S Leyh

Open access · goldAbstract read
In one paragraph

Article in The Journal of biological chemistry. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Ting WangDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA.
Ian CookDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA.
Thomas S LeyhDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA. Electronic address: tom.leyh@einsteinmed.org.
Albert Einstein College of Medicine · US

Funding

The Study of Human Sulfuryl-Transfer BiologyR35GM127144 · NIGMS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI LEYH, THOMAS S. · 2018 to 2022
$2.3M
Allosteric Regulation of Human Cytosolic SulfotransferasesR01GM121849 · NIGMS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI LEYH, THOMAS S. · 2017 to 2018
$888k
Console and probe upgrade for 600 MHz NMRS10OD016305 · OD · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI COWBURN, DAVID · 2014 to 2014
$595k
NIGMS NIH HHS R01 GM121849NIGMS NIH HHS R35 GM127144NIH HHS S10 OD016305
6 · The paper itself

Abstract

Polychlorinated bisphenols (PCBs) continue to contaminate food chains globally where they concentrate in tissues and disrupt the endocrine systems of species throughout the ecosphere. Hydroxylated PCBs (OH-PCBs) are major PCB metabolites and high-affinity inhibitors of human estrogen sulfotransferase (SULT1E1), which sulfonates estrogens and thus prevents them from binding to and activating their receptors. OH-PCB inhibition of SULT1E1 is believed to contribute significantly to PCB-based endocrine disruption. Here, for the first time, the molecular basis of OH-PCB inhibition of SULT1E1 is revealed in a structure of SULT1E1 in complex with OH-PCB1 (4'-OH-2,6-dichlorobiphenol) and its substrates, estradiol (E2), and PAP (3'-phosphoadenosine-5-phosphosulfate). OH-PCB1 prevents catalysis by intercalating between E2 and catalytic residues and establishes a new E2-binding site whose E2 affinity and positioning are greater than and competitive with those of the reactive-binding pocket. Such complexes have not been observed previously and offer a novel template for the design of high-affinity inhibitors. Mutating residues in direct contact with OH-PCB weaken its affinity without compromising the enzyme's catalytic parameters. These OH-PCB resistant mutants were used in stable transfectant studies to demonstrate that OH-PCBs regulate estrogen receptors in cultured human cell lines by binding the OH-PCB binding pocket of SULT1E1.

Indexed as

Enzyme InhibitorsEstrogensHumansHydroxylationModels, MolecularPolychlorinated BiphenylsReceptors, EstrogenSulfotransferasesEnzyme InhibitorsEstrogensestrone sulfotransferasePolychlorinated BiphenylsReceptors, EstrogenSulfotransferasesestrogen-receptor activationhydroxylated PCBinhibitor designmolecular dynamicspolychlorinated biphenylspin-label NMR structuresulfotransferase 1E1

Identifiers

PMID33524392
PMCPMC7949139
OpenAlexW3129095941

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.